Natasha Hernday

Insider Reports History

Entity
Individual
Location
932 Southwood Blvd, Incline Village, NV
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Natasha Hernday:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 6.23K $341K $54.75 Jul 19, 2024 Direct
XOMA Corp Director Common Stock 3.04K $42.2K $13.89 May 15, 2024 Direct
XOMA Corp Director Non-Qualified Share Option (right to buy) 4.88K May 15, 2024 Direct
Janux Therapeutics, Inc. Director Stock Option (Right to Buy) 4.11K Jul 19, 2024 Direct
ALPINE IMMUNE SCIENCES, INC. Director Stock Option (Right to buy) 0 May 20, 2024 Direct

Insider Reports Filed by Natasha Hernday

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jul 19, 2024 2 $0 4/A Jul 24, 2024 Director
JANX Janux Therapeutics, Inc. Jul 19, 2024 4 $0 4 Jul 22, 2024 Director
JANX Janux Therapeutics, Inc. Jul 19, 2024 0 $0 3 Jul 22, 2024 Director
ALPN ALPINE IMMUNE SCIENCES, INC. May 20, 2024 5 $0 4 May 20, 2024 Director
XOMA XOMA Corp May 15, 2024 2 $0 4 May 17, 2024 Director
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
XOMA XOMA Corp May 17, 2023 1 $0 4 May 19, 2023 Director
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
XOMA XOMA Corp May 18, 2022 1 $0 4 May 20, 2022 Director
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 3, 2022 1 $0 4 Jan 4, 2022 Director
XOMA XOMA Corp May 19, 2021 1 $0 4 May 21, 2021 Director